The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Heterogeneity of liver cancer and personalized therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
The Association of HMGB1 Gene with the Prognosis of HCC
Xiao, J., Ding, Y., Huang, J., Li, Q., Liu, Y., Ni, W., Zhang, Y., Zhu, Y., Chen, L., & Chen, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089097 · Cited by 53
RetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
WHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Forner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C.-C., Hwang, L.-Y., & Chien, C.-S. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,865
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Metastasis Results from Preexisting Variant Cells Within a Malignant Tumor
Fidler, I. J., & Kripke, M. L. (1977) · Science · doi:10.1126/science.887927 · Cited by 1,425
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Levine, A. J., & Puzio-Kuter, A. M. (2010) · Science · doi:10.1126/science.1193494 · Cited by 1,243
Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor Cells
Ma, S., Chan, K., Hu, L., Lee, T. K., Wo, J. Y., Ng, I. O., Zheng, B., & Guan, X. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.025 · Cited by 1,192
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P. W. K., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,162
Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,149
Self-citationThe Epidemiology of Cholangiocarcinoma
Shaib, Y., & El-Serag, H. (2004) · Seminars in Liver Disease · doi:10.1055/s-2004-828889 · Cited by 1,132
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
Arzumanyan, A., Reis, H. M. G. P. V., & Feitelson, M. A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3449 · Cited by 800
Marrero, J. A., Feng, Z., Wang, Y., Nguyen, M. H., Befeler, A. S., Roberts, L. R., Reddy, K. R., Harnois, D., Llovet, J. M., Normolle, D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.005 · Cited by 745
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
Zhou, J., Yu, L., Gao, X., Hu, J., Wang, J., Dai, Z., Wang, J.-F., Zhang, Z., Lu, S., Huang, X., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2697 · Cited by 635
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Non-alcoholic fatty liver disease: The mist gradually clears
de Alwis, N. M. W., & Day, C. P. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.009 · Cited by 603
Lee, T. K. W., Castilho, A., Cheung, V. C. H., Tang, K. H., Ma, S., & Ng, I. O. L. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.005 · Cited by 586
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Heterogeneity of tumor cells from a single mouse mammary tumor.
Dexter, D. L., Kowalski, H. M., Blazar, B. A., Fligiel, Z., Vogel, R., & Heppner, G. H. (1978) · PubMed · Cited by 579
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
The Enigmatic X Gene of Hepatitis B Virus
Bouchard, M. J., & Schneider, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12725-12734.2004 · Cited by 498
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
Roayaie, S., Schwartz, J. D., Sung, M. W., Emre, S. H., Miller, C. M., Gondolesi, G. E., Krieger, N. R., & Schwartz, M. E. (2004) · Liver Transplantation · doi:10.1002/lt.20128 · Cited by 455
Mutational landscape of intrahepatic cholangiocarcinoma
Zou, S., Li, J., Zhou, H., Frech, C., Jiang, X., Chu, J. S. C., Zhao, X., Li, Y., Li, Q., Wang, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6696 · Cited by 434
Self-citationRecurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shah, S. A., Cleary, S. P., Wei, A. C., Yang, I., Taylor, B. R., Hemming, A. W., Langer, B., Grant, D. R., Greig, P. D., & Gallinger, S. (2007) · Surgery · doi:10.1016/j.surg.2006.06.028 · Cited by 420
PTEN-deficient intestinal stem cells initiate intestinal polyposis
He, X. C., Yin, T., Grindley, J. C., Tian, Q., Sato, T., Tao, W. A., Dirisina, R., Porter-Westpfahl, K. S., Hembree, M., Johnson, T., et al. (2007) · Nature Genetics · doi:10.1038/ng1928 · Cited by 417
Self-citationPoon, D., Anderson, B. O., Chen, L.-T., Tanaka, K., Lau, W. Y., Van Cutsem, E., Singh, H., Chow, W. C., Ooi, L. L., Chow, P., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70241-4 · Cited by 410
PTEN, more than the AKT pathway
Blanco-Aparicio, C., Renner, O., Leal, J. F. M., & Carnero, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm052 · Cited by 403
Cell Plasticity and Heterogeneity in Cancer
Marjanovic, N. D., Weinberg, R. A., & Chaffer, C. L. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.184655 · Cited by 400
Shen, Q., Fan, J., Yang, X.-R., Tan, Y., Zhao, W., Xu, Y., Wang, N., Niu, Y., Wu, Z., Zhou, J., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70233-4 · Cited by 394
Self-citationGP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
Marrero, J. A., Romano, P. R., Nikolaeva, O., Steel, L., Mehta, A., Fimmel, C. J., Comunale, M. A., D'Amelio, A., Lok, A. S., & Block, T. M. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.028 · Cited by 364
Kuper, H., Tzonou, A., Kaklamani, E., Hsieh, C.-C., Lagiou, P., Adami, H.-O., Trichopoulos, D., & Stuver, S. O. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000215)85:4<498::aid-ijc9>3.0.co;2-f · Cited by 350
Yu, L.-X., Yan, H.-X., Liu, Q., Yang, W., Wu, H.-P., Dong, W., Tang, L., Lin, Y., He, Y.-Q., Zou, S.-S., et al. (2010) · Hepatology · doi:10.1002/hep.23845 · Cited by 349
Self-citationIs obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair, S., Mason, A., Eason, J., Loss, G., & Perrillo, R. P. (2002) · Hepatology · doi:10.1053/jhep.2002.33713 · Cited by 348
Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study
Chalasani, N., Baluyut, A., Ismail, A., Zaman, A., Sood, G., Ghalib, R., McCashland, T. M., Reddy, R. K., Zervos, X., Anbari, M. A., et al. (2000) · Hepatology · doi:10.1002/hep.510310103 · Cited by 336
Progenitor/stem cells give rise to liver cancer due to aberrant TGF-β and IL-6 signaling
Tang, Y., Kitisin, K., Jogunoori, W., Li, C., Deng, C.-X., Mueller, S. C., Ressom, H. W., Rashid, A., He, A. R., Mendelson, J. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705395105 · Cited by 310
Yin, J., Li, N., Han, Y., Xue, J., Deng, Y., Shi, J., Guo, W., Zhang, H., Wang, H., Cheng, S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5896 · Cited by 307
Self-citationHepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Kondo, Y., Kanai, Y., Sakamoto, M., Mizokami, M., Ueda, R., & Hirohashi, S. (2000) · Hepatology · doi:10.1053/jhep.2000.19797 · Cited by 273
Donato, F., Gelatti, U., Tagger, A., Favret, M., Ribero, M. L., Callea, F., Martelli, C., Savio, A., Trevisi, P., & Nardi, G. (2001) · Cancer Causes & Control · doi:10.1023/a:1013747228572 · Cited by 247
EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation
Lanaya, H., Natarajan, A., Komposch, K., Li, L., Amberg, N., Chen, L., Wculek, S. K., Hammer, M., Zenz, R., Peck-Radosavljevic, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3031 · Cited by 242
Self-citationYan, W., Chang, Y., Liang, X., Cardinal, J. S., Huang, H., Thorne, S. H., Monga, S. P. S., Geller, D. A., Lotze, M. T., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25572 · Cited by 241
Wang, X. Q., Ongkeko, W. M., Chen, L., Yang, Z. F., Lu, P., Chen, K. K., Lopez, J. P., Poon, R. T. P., & Fan, S. T. (2010) · Hepatology · doi:10.1002/hep.23692 · Cited by 238
Role of nuclear receptor SHP in metabolism and cancer
Zhang, Y., Hagedorn, C. H., & Wang, L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.10.006 · Cited by 235
Li, L., Chen, L., Hu, L., Liu, Y., Sun, H.-Y., Tang, J., Hou, Y.-J., Chang, Y.-X., Tu, Q.-Q., Feng, G.-S., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 234
Self-citationIs cancer a disease of abnormal cellular metabolism? New angles on an old idea
Deberardinis, R. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31818b0d9b · Cited by 219
Lim, K.-C., Chow, P. K.-H., Allen, J. C., Siddiqui, F. J., Chan, E. S.-Y., & Tan, S.-B. (2012) · British Journal of Surgery · doi:10.1002/bjs.8915 · Cited by 219
Serum Proteomics and Biomarkers in Hepatocellular Carcinoma and Chronic Liver Disease
Zinkin, N. T., Grall, F., Bhaskar, K., Otu, H. H., Spentzos, D., Kalmowitz, B., Wells, M., Guerrero, M., Asara, J. M., Libermann, T. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0586 · Cited by 207
Wu, K., Ding, J., Chen, C., Sun, W., Ning, B.-F., Wen, W., Huang, L., Han, T., Yang, W., Wang, C., et al. (2012) · Hepatology · doi:10.1002/hep.26007 · Cited by 204
Self-citationLiver cancer in Thailand. I. A case‐control study of cholangiocarcinoma
Parkin, D. M., Srivatanakul, P., Khlat, M., Chenvidhya, D., Chotiwan, P., Insiripong, S., L'abbé, K. A., & Wild, C. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480302 · Cited by 191
Present and future possibilities for early diagnosis of hepatocellular carcinoma
Stefaniuk, P. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i4.418 · Cited by 184
Lin, C.-W., Lin, C.-C., Mo, L.-R., Chang, C.-Y., Perng, D.-S., Hsu, C.-C., Lo, G.-H., Chen, Y.-S., Yen, Y.-C., Hu, J.-T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.045 · Cited by 174
Nan, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1197 · Cited by 150
Wang, C., Yang, W. K., Yan, H., Luo, T., Zhang, J., Tang, L. V., Wu, F., Zhang, H., Yu, L., Zheng, L., et al. (2011) · Hepatology · doi:10.1002/hep.24675 · Cited by 149
Self-citationLi, L., Tang, J., Zhang, B.-H., Yang, W., LiuGao, M., Wang, R.-Y., Tan, Y., Fan, J.-L., Chang, Y.-X., Fu, J., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305715 · Cited by 136
Self-citationFu, J., Chen, Y., Cao, J., Luo, T., Qian, Y., Yang, W. K., Ren, Y., Su, B., Cao, G., Yang, Y., et al. (2010) · Hepatology · doi:10.1002/hep.24015 · Cited by 134
Self-citationGebo, K. A., Chander, G., Jenckes, M. W., Ghanem, K. G., Herlong, H. F., Torbenson, M. S., El‐Kamary, S. S., & Bass, E. B. (2002) · Hepatology · doi:10.1053/jhep.2002.36817 · Cited by 131
Noda, T., Nagano, H., Takemasa, I., Yoshioka, S., Murakami, M., Wada, H., Kobayashi, S., Marubashi, S., Takeda, Y., Dono, K., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605064 · Cited by 122
Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome
Chen, W.-T., Chau, G., Lui, W. Y., Tsay, S. H., King, K., Loong, C. C., & Wu, C.-W. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.01.013 · Cited by 112
O'Dwyer, P. J., Giantonio, B. J., Levy, D. E., Kauh, J. S. W., Fitzgerald, D. B., & Benson, A. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.4143 · Cited by 106
Wnt/β-Catenin Pathway in Hepatocellular Carcinoma Pathogenesis and Liver Physiology
Cavard, C., Colnot, S., Audard, V., Benhamouche, S., Finzi, L., Torre, C., Grimber, G., Godard, C., Terris, B., & Perret, C. (2008) · Future Oncology · doi:10.2217/14796694.4.5.647 · Cited by 102
Calvisi, D. F., Factor, V. M., Ladu, S., Conner, E. A., & Thorgeirsson, S. S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.014 · Cited by 100
Chen, M., Liu, Y., Varley, P. R., Chang, Y., He, X.-X., Huang, H., Tang, D., Lotze, M. T., Lin, J., & Tsung, A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2147 · Cited by 98
Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
Tu, T., Budzinska, M. A., Maczurek, A. E., Cheng, R., Bartolomeo, A. D., Warner, F. J., McCaughan, G. W., McLennan, S. V., & Shackel, N. A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15069422 · Cited by 94
Radiofrequency Ablation of Hepatocellular Carcinoma: A Literature Review
Minami, Y., & Kudo, M. (2011) · International Journal of Hepatology · doi:10.4061/2011/104685 · Cited by 93
Gebo, K. A., Chander, G., Jenckes, M. W., Ghanem, K. G., Herlong, H. F., Torbenson, M. S., El‐Kamary, S. S., & Bass, E. B. (2002) · Hepatology · doi:10.1002/hep.1840360711 · Cited by 86
Tsuchiya, M., Parker, J. S., Kono, H., Matsuda, M., Fujii, H., & Rusyn, I. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-74 · Cited by 78
Faivre, S. J., Raymond, É., Douillard, J., Boucher, É., Lim, H. Y., Js, K., Lanzalone, S., Lechuga, M. J., Sherman, L. J., & Cheng, A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3546 · Cited by 71
Yamada, C., Ozaki, T., Ando, K., Suenaga, Y., Inoue, K., Ito, Y., Okoshi, R., Kageyama, H., Kimura, H., Miyazaki, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.055525 · Cited by 70
Hypoxic Suppression of the Cell Cycle GeneCDC25Ain Tumor Cells
Hammer, S., To, K. K. W., Yoo, Y., Koshiji, M., & Huang, E. L. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4515 · Cited by 67
Tang, J. P., Li, L., Huang, W., Sui, C., Yang, Y., Lin, X., Hou, G., Chen, X., Fu, J., Yuan, S., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.023 · Cited by 64
Self-citationSurgical management of hepatocellular carcinoma: Is the jury still out?
Morris‐Stiff, G., Gomez, D., Carino, N. D. L., & Prasad, R. K. (2008) · Surgical Oncology · doi:10.1016/j.suronc.2008.08.003 · Cited by 62
Evolution of Genomic Instability in Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice Δ
Aleksic, K., Lackner, C., Geigl, J. B., Schwarz, M., Auer, M., Ulz, P., Fischer, M., Trajanoski, Z., Otte, M., & Speicher, M. R. (2010) · Hepatology · doi:10.1002/hep.24133 · Cited by 57
Liu, F., Zhang, Y., Peng, Z., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-135 · Cited by 56
Schwartz, J. D., Schwartz, M., Lehrer, D., Cohen, E. I., Sung, M. W., Kinkhabwala, M. M., Siegel, A. B., Holloway, S., Ocean, A. J., & Wadler, S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.4144 · Cited by 55
Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment
Carey, W. D., & Sherman, M. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s3.02 · Cited by 53
Pan, Y., Tan, Y., Wang, M., Zhang, J., Zhang, B., Yang, C., Ding, Z., Dong, L., & Wang, H. (2013) · Hepatology · doi:10.1002/hep.26391 · Cited by 46
Self-citationImmunotherapy for hepatocellular carcinoma: From basic research to clinical use
Hong, Y., Li, Z.-D., Prasoon, P., & Zhang, Q. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.980 · Cited by 40
Molecular mechanisms of cholangiocarcinoma
Fava, G. (2010) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v1.i1.12 · Cited by 32
Potential role of High mobility group box 1 in hepatocellular carcinoma
Zhou, R.-R., Kuang, X.-Y., Huang, Y., et al. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.969139 · Cited by 30
Hu, L., Chen, L., Liang, L., Sun, H., Yang, G.-Z., Chang, Y., Tu, Q., Wu, M., & Wang, H. (2011) · Journal of Virology · doi:10.1128/jvi.01841-10 · Cited by 28
Self-citationImmunobiology of hepatocellular carcinoma
Flecken, T., Spangenberg, H. C., & Thimme, R. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0783-x · Cited by 23
Cited by
Tang, W., Chen, Z., Zhang, W., Cheng, Y., Zhang, B., Wu, F., Wang, Q., Wang, S., Rong, D., Reiter, F. P., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0187-x · Cited by 997
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Chan, Y.-T., Zhang, C., Wu, J., Lu, P., Xu, L., Yuan, H., Feng, Y., Chen, Z.-S., & Wang, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02101-z · Cited by 281
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Chen, S., Cao, Q., Wen, W., & Wang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114428 · Cited by 255
Self-citationFan, Q., Yang, L., Zhang, X., Ma, Y., Li, Y., Dong, L., Zong, Z., Hua, X., Su, D., Li, H., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0673-y · Cited by 216
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine
Xie, F., Sun, L., Pang, Y., Xu, G., Jin, B., Xu, H., Lu, X., Xu, Y., Du, S., Wang, Y., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120416 · Cited by 147
Metadata
- Authors
- Li, L., & Wang, H.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2016-09
- Volume
- 379
- Issue
- 2
- Pages
- 191-197
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1038682962
- Cited by
- 339
- References
- 104
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.